Pricing & Market Access Due Diligence Support
Pricing & Market Access Due Diligence Support
Company interested in acquiring novel product for orphan tumour type in a tight turnaround window, but pricing a large uncertainty
Company interested in acquiring novel product for orphan tumour type in a tight turnaround window, but pricing a large uncertainty
Examined pricing and reimbursement analogues of therapeutics for similar- prevalence conditions. Conducted a regression analysis that predicted the likely reimbursed price for a novel oncologic given a specific prevalence. Applied this, as well as early cost-utility analysis and payer interviews to support a commercially-viable price for the deal
Examined pricing and reimbursement analogues of therapeutics for similar- prevalence conditions. Conducted a regression analysis that predicted the likely reimbursed price for a novel oncologic given a specific prevalence. Applied this, as well as early cost-utility analysis and payer interviews to support a commercially-viable price for the deal
All work was completed in time for Board meeting and approval, resulting in acquisition of the asset
All work was completed in time for Board meeting and approval, resulting in acquisition of the asset